Adamis Pharmaceuticals Corp

Most Recent

  • uploads///epipen
    Earnings Report

    Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead

    During its second-quarter earnings release on August 8, Mylan provided an update on its EpiPen supply shortages.

    By Sarah Collins
  • uploads///approved _
    Company & Industry Overviews

    FDA Approves Teva’s Generic Version of EpiPen, Stock Up 7.5%

    Teva Pharmaceutical Industries (TEVA) received FDA approval for the generic version of Mylan’s (MYL) allergy products EpiPen and EpiPen Jr.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.